MolecuLight Revenue and Competitors
Estimated Revenue & Valuation
- MolecuLight's estimated annual revenue is currently $7.5M per year.
- MolecuLight's estimated revenue per employee is $125,500
- MolecuLight's total funding is $29.2M.
Employee Data
- MolecuLight has 60 Employees.
- MolecuLight grew their employee count by 15% last year.
MolecuLight Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $31.1M | 124 | -4% | N/A | N/A |
#2 | $4M | 16 | -6% | N/A | N/A |
#3 | $78.3M | 312 | 9% | N/A | N/A |
#4 | $23.1M | 92 | 6% | N/A | N/A |
#5 | $9.3M | 37 | 9% | N/A | N/A |
#6 | $75.3M | 240 | 3% | $53.9M | N/A |
#7 | $267.6M | 1066 | 13% | N/A | N/A |
#8 | $36.6M | 0 | N/A | $1.3B | N/A |
#9 | $30.9M | 123 | -20% | N/A | N/A |
#10 | $8.5M | 34 | -17% | N/A | N/A |
What Is MolecuLight?
ABOUT US: MolecuLight Inc. is a privately owned, Canadian medical imaging company founded by Dr. Ralph DaCosta and incorporated on June 1, 2012. The company?s first product, the MolecuLight i:X, is a first-of-its kind handheld imaging device based on Dr. DaCosta?s invention. MolecuLight is based in Toronto, Canada and has an exclusive global distributor partnership with Smith & Nephew. OUR MISSION: MolecuLight?s mission is to become the ubiquitous name in fluorescence-guided imaging technologies to improve health outcomes for patients globally through innovative products and services that optimize the delivery of health care and become standard of care in wound care and breast cancer. DISCLAIMER: The MolecuLight i:X? Imaging Device is approved by Health Canada (Medical License #95784) and has CE marking (Certificate #G1160292355002) for sale in Canada and the European Union. The MolecuLight i:X? Imaging Device has received FDA De Novo clearance. MolecuLight® and Look to Heal® are registered trademarks in Canada, the US and the EU. Follow us on Twitter and YouTube: @moleculight
keywords:N/A
$29.2M
Total Funding
60
Number of Employees
$7.5M
Revenue (est)
15%
Employee Growth %
N/A
Valuation
N/A
Accelerator
MolecuLight's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Regional Sales Manager | Reveal Email/Phone |
2 | Regional Sales Manager | Reveal Email/Phone |
3 | Clinical Product Specialist | Reveal Email/Phone |
4 | VP, Reimbursement | Reveal Email/Phone |
5 | Project Manager, Technical | Reveal Email/Phone |
6 | Director, Clinical Trials and Health Economics | Reveal Email/Phone |
7 | Graphic Designer | Reveal Email/Phone |
8 | COO | Reveal Email/Phone |
9 | Director, Regulatory Affairs, Compliance & Quality | Reveal Email/Phone |
10 | Regional Sales Manager | Reveal Email/Phone |
MolecuLight News
KOVE Inc. to Distribute the MolecuLight Product Suite to Large South Korean Wound Care Market. TORONTO and SEOUL, South Korea, April 6,...
Other Companies in Toronto
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $14.6M | 60 | 0% | N/A |
#2 | $6.5M | 60 | 9% | N/A |
#3 | $11.3M | 60 | -6% | N/A |
#4 | $13.1M | 60 | -17% | N/A |
#5 | $7.6M | 60 | 40% | $13M |
MolecuLight Executives
| Name | Title |
|---|---|
| Desmond Hirson | COO |
| Anil Amlani | CEO at MolecuLight Inc |
| Rob Sandler | Chief Marketing Officer |
| Ralph DaCosta | Founder, CSO, Director |
| Nitesh Mistry | Vice President, Manufacturing |
| Martha Yannessa | Executive VP of Sales, Americas |
| Monique Rennie | Vice President, Reimbursement |
| Monique Rennie | VP, Medical Affairs & Reimbursement |